Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Thrombin substrate used to measure thrombin act...
Valsartan impurity
Alkaloid found in Corydalis and Stephania; D1/2...
Alkaloid found in plants in the Amaryllidaceae ...
Viral M2 proton channel blocker, MAO-A, NET, NM...
MAGL inhibitor.
Six-histidine peptide used for affinity column ...
Mycotoxin contaminant found in cereal grains.
Antimicrobial peptide found in Trichoderma, ind...
5-HT1A partial agonist, 5-HT2, histamine, α1/2...
PRMT5 inhibitor
ET-A/B antagonist.
Semi-synthetic diterpene originally found in Ta...
Fibrate; PPARα agonist.
Sphingosine 1-phosphate antagonist.
FGFR inhibitor.
Amphibian tachykinin neuropeptide.
NSAID; COX-1/2 inhibitor.
GPR17 agonist, NMDA and fructose 1,6-bisphospha...
β-adrenergic agonist.